For Immediate Assistance Call 1-800-966-2244
Mesothelioma News

Patients With Unresectable Mesothelioma Gain Potent New Treatment Option

Speaking of the challenges faced by patients diagnosed with malignant mesothelioma, lead investigator Raffit Hassan, MD, Thoracic and GI Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland explained that, “Patients with malignant mesothelioma whose disease has progressed after platinum and pemetrexed treatment have limited options.” This statement underlines the need to find a course of treatment that will be both safe and effective.

Writing in the journal JAMA Oncology of the results of a study he and his colleagues conducted, Hassan explains that previous research had already shown that the drug demonstrated anti tumor activity against mesothelioma tumors, but that research had not actually been conducted on actual patients who had previously been treated with other chemotherapy treatments. The group examined the results achieved in a group of 53 patients who were treated between September 2014 and July 2015 at a variety of facilities in the United States and around the world. Patients treated with avelumab, many of whom had previously undergone as many as three or more chemotherapy treatments, experienced positive progression-free survival, including one with a complete response and four with what is considered partial responses. Most encouraging of all, the median progression-free survival was 4.1 months and the 12-month progression free survival rate was 17.4 percent, while those with positive responses had median overall survival of 15.2 months. The researchers concluded that “Avelumab showed durable antitumor activity and disease control with an acceptable safety profile in a heavily pretreated cohort of patients with mesothelioma.”

If you have been diagnosed with malignant mesothelioma, it means that you were exposed to asbestos at some point in your life. If you need information on getting assistance in pursuing justice from those who are responsible for your illness, we can help. Contact us today at 1-800-966-2244.

Author: Terri Oppenheimer

Terri Oppenheimer

Terri Oppenheimer is an independent writer, editor, and proofreader. She graduated from the College of William and Mary with a degree in English. Her dreams of a writing career were diverted by a need to pay her bills. She spent a few years providing the copy for a major retailer, then landed a lucrative career in advertising sales. With college bills for all three of her kids paid, she left corporate America for a return to her original goal of writing. She specializes in providing content for websites and finds tremendous enjoyment in the things she learns while doing her research. Her specific areas of interest include health and fitness, medical research, and the law.